OXFV...big volume/price spike today!

[gmarc66]

Just an FYI, there seems to be alot of attention on other boards in regards to OXFV....so this may continue higher today. I am still holding shares, so I will be watching carefully to try to maximize my profits.

But, please be careful for anyone still holding...i still never trust penny stocks...never know exactly what they will do. However, the interest in OXFV is reassuring, so I am expecting this to do some more...I wonder where it will go?  If it does manage to break the .012 that would be great, from there it will be uncharted territory...lets hope for a very green day

Good luck to everyone....lets get us some profits...i'm sure everybody will happily welcome them after experiencing such a bearish market as of late.


julia

[gmarc66]

Mid day news:

2005-11-16 14:19:01 
ULURU Receives First U.S. Army SBIR Funding; Partnered with University of Texas Southwestern Medical Center to Develop Nanoparticle Aggregate Technology 



DALLAS--(BUSINESS WIRE)--Nov. 16, 2005--
ULURU INC. ("ULURU") who has signed a definitive merger
agreement with Oxford Ventures, Inc. (OTC Bulletin Board: OXFV) today
announced the receipt of funding for a Department of Defense SBIR
Phase I Grant award.
The U.S. Army SBIR Program awarded to ULURU funding for the
proposal titled, "Chemical Casualty Care: Hydrogel Nanoparticle
Aggregates as Wound Dressings Following Debridement of Cutaneous
Vesicant Injuries." The Phase I SBIR Proposal has a period of
performance of six months from November 14, 2005 to June 13, 2006.
ULURU is partnered with the Department of Plastic Surgery at the
University of Texas Southwestern Medical School (UTSW) in Dallas. UTSW
will provide preclinical and clinical direction in the development of
this platform nanoparticle aggregate technology as a standard of care
for chemically burned tissue regeneration. The objective of the Phase
I proposal is to achieve an optimal nanoparticle aggregate wound
dressing design based on in vitro and in vivo proof-of-concept
experiments. We believe that our relationship with UTSW maximizes the
potential for advantages of this technology to be translated into
clinical benefits through the design and testing of our technology in
appropriate wound healing models. These studies will compare the
nanoparticle aggregate system with standard dressings. Commenting on
the SBIR award and relationship between UTSW and Uluru, Spencer Brown,
PhD, Director of Research, Nancy Lee & Perry Bass Advanced Wound
Healing Laboratory in the Department of Plastic Surgery at UTSW states
that, "This award provides for the development of a new generation of
wound dressings using Uluru's novel, platform technology. The
materials that provide the best care for surgical patients will be
identified through an advanced, evidence-based process."
In conjunction with UTSW, ULURU has initiated in vivo studies in a
burn-healing model and these data will form the basis for a $1 million
fast-track Phase II SBIR Grant proposal to clinically develop and
demonstrate the efficacy of a wound dressing. Phase II funding will
therefore involve extensive human clinical trials under the guidance
of the Department of Plastic Surgery at UTSW Medical School.
Commenting on the UTSW relationship Kerry P. Gray, President and
CEO of ULURU stated, "We are delighted to be collaborating with the
UTSW Department of Plastic Surgery, which is one of the premier groups
in this field in the United States. We believe that utilizing their
capabilities significantly enhances the potential for the development
of products utilizing our nanoparticle aggregate technology in burn
care, wound management and as dermal fillers."

ULURU Inc. is an emerging specialty pharmaceutical company focused
on the development of a portfolio of topical delivery technologies to
provide patients and consumers improved clinical outcomes through
controlled delivery utilizing its innovative transmucosal delivery
system and Hydrogel Nanoparticle Aggregate Technology.

[gmarc66]

Well...the news sounded good....then after market close they release news of a R/S coming....great...holding the bag again

glta

julia

[runforthedoor]

  Julia...while most big R/S's in pennyland are very bad news....occaisionally there is a good reason behind it. I'm wondering that with OXFV, due to their recent merger/news/etc.... here's a post from another board.....

"OXFV is going to AMEX!? After 400 to 1 reverse split, OXFV share price ($1.6) will meet AMEX listing standard. We have been waiting for this reverse split since 9/13. This is a typical reverse merge. Kerry Gray has 2 investment firms behind."

  You may not have such a bad bag here. Tommorrow will be interesting to see how it is received. 

[gmarc66]

well..that's interesting RFTD...guess i will just watch in the am to see what happens.

Can i ask u were from which site u got that quote from?

thanks!

julia

[gnlbigte]

julia...its from allstocks.com I guess...I am also watching this tomorrow...keep a watch on L2 for SCHB, NITE and ETRD..decide based on their moves...they control 80%+ of OXFV trades...

OXFV - OXFORD VENTURES INC
        Page  of 1   

   October 2005    September 2005    Year-to-Date   
  Volume  Rank  %    Volume  Rank  %    Volume  Rank  %   

--------------------------------------------------------------------------------

Total Share Volume  920,069,196   

--------------------------------------------------------------------------------

SCHB
UBS CAPITAL MARKETS L.P. 432,350,603   1   46        285,019,042   1   45        826,548,388   1   42   
NITE
KNIGHT EQUITY MARKETS, L.P. 283,834,807   2   30        144,013,296   2   23        482,525,688   2   25   
ETRD
E*TRADE CAPITAL MARKETS LLC 116,258,449   3   12        79,922,757   3   12        220,062,541   3   11

[gmarc66]

Thanks for the advice gnlbigte ..but, unfortunately i don't have L2

good luck

julia